A Phase I/II Study of CX5461

Trial Profile

A Phase I/II Study of CX5461

Phase of Trial: Phase I/II

Latest Information Update: 26 Mar 2018

At a glance

  • Drugs CX 5461 (Primary)
  • Indications Advanced breast cancer; Solid tumours
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 07 Mar 2018 Results (n=24) of phase 1 part presented at the 16th International Congress on Targeted Anticancer Therapies
    • 15 Jun 2016 Status changed from not yet recruiting to recruiting.
    • 29 Mar 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top